ER-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with ER-Positive Breast Cancer — Part 1

Featuring perspectives from Dr Virginia Kaklamani, including the following topics: Introduction: Adjuvant Therapy for Breast Cancer — NIH Consensus Statement 2000 (0:00) Case: A premenopausal woman in her early 30s with high-risk localized ER-positive breast cancer — Susmitha Apuri, MD (15:06) Case: A premenopausal woman in her late 40s with localized ER-positive, node-positive breast cancer — Recurrence Score® 14 — Reshma Mahtani, DO (20:22) Case: A premenopausal woman in her mid-40s with localized ER-positive breast cancer — Ruth O’Regan, MD (22:28) Case: A woman in her mid-80s with ER-positive metastatic breast cancer (mBC) — Vikas Malhotra, MD (28:51) Case: A woman in her late 60s with ER-positive mBC — PIK3CA mutation, microsatellite stable, tumor mutation burden 20 mut/Mb — Mamta Choksi, MD (37:36) ESMO 2021 Review (43:20) Case: A woman in her late 50s with ER-positive mBC — PD-L1-negative — Debra Patt, MD, PhD, MBA (50:50) Beyond the Guidelines (53:52) CME information and select publications